Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Humoral Immunity in Type 1 Diabetes Mellitus
Massimo Pietropaolo
, Mark A. Sperling
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Humoral Immunity in Type 1 Diabetes Mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Humoral Immunity
100%
Autoantibodies
50%
Autoimmune Disease
25%
Diabetes Mellitus Patients
25%
Newly Diagnosed
12%
Disease Stage
12%
Family Members
12%
Genetic Factors
12%
Environmental Factors
12%
Pancreatic Cells
12%
Insulin
12%
Predictive Value
12%
Relative Risk
12%
Intervention Studies
12%
T-cell Mediated
12%
Significant Loss
12%
Surrogate Marker
12%
Complex Interactions
12%
Islet
12%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
12%
Immunomodulation
12%
Risk Determinants
12%
Immunological Diagnosis
12%
Immunologic Markers
12%
Biochemistry, Genetics and Molecular Biology
Humoral Immunity
100%
Autoantibodies
100%
Autoimmunity
50%
Genetics
25%
T Cell
25%
Immunomodulation
25%
Intervention Trial
25%
Wassermann Test
25%
Immunology and Microbiology
Humoral Immunity
100%
Diabetes Mellitus Type 1
100%
Autoantibodies
50%
Autoimmune Disease
25%
Insulin
25%
T Cell
12%
Immunomodulation
12%